Suppression of Adipogenesis by Pathogenic Seipin Mutant Is Associated with Inflammatory Response

Abstract

These results suggest that pathogenic Seipin-A212P inhibits adipogenesis and the inhibition is associated with activation of inflammatory pathways at pre-differentiation stages. Use of anti-inflammatory drugs may be a potential strategy for the treatment of lipodystrophy.